Starting Dose for Heparin Drip
For therapeutic anticoagulation in adults without renal impairment or bleeding risks, initiate heparin with an 80 units/kg IV bolus followed by 18 units/kg/hour continuous infusion. 1, 2, 3, 4
Weight-Based Dosing Protocol
The weight-based approach is superior to fixed-dose regimens and achieves therapeutic anticoagulation more rapidly with lower recurrence rates:
- Initial bolus: 80 units/kg IV 1, 2, 3
- Continuous infusion: 18 units/kg/hour 1, 2, 3
- Target aPTT: 1.5-2.5 times control value (approximately 50-70 seconds) 2, 3, 4
This regimen is based on landmark randomized controlled trial data showing that patients receiving weight-based dosing achieved therapeutic aPTT within 24 hours in 97% of cases versus only 77% with fixed dosing, and experienced significantly fewer recurrent thromboembolic events. 1, 5
Alternative FDA-Approved Fixed-Dose Regimen
If weight-based dosing is not feasible, the FDA label provides an alternative:
- Initial bolus: 5,000 units IV 1, 4
- Continuous infusion: 20,000-40,000 units/24 hours (approximately 32,000 units/24 hours or ~1,333 units/hour) 1, 4
However, this fixed-dose approach is less effective than weight-based dosing and should only be used when weight-based protocols are unavailable. 1, 5
Monitoring Requirements
First aPTT measurement: Obtain 6 hours after initiating therapy 2, 3, 4
Subsequent monitoring: Every 4-6 hours until stable in therapeutic range, then daily 2, 3, 4
Baseline labs: Check aPTT, INR, platelet count, hematocrit before starting therapy 4
Ongoing surveillance: Monitor platelet counts periodically throughout therapy to detect heparin-induced thrombocytopenia 4
Dose Adjustment Algorithm
Adjust infusion rate based on aPTT results using the following protocol 2:
- aPTT <35 seconds: Give 80 units/kg bolus, increase infusion by 4 units/kg/hour 2
- aPTT 35-45 seconds: Give 40 units/kg bolus, increase infusion by 2 units/kg/hour 2
- aPTT 46-70 seconds: No change (therapeutic range) 2
- aPTT 71-90 seconds: Decrease infusion by 2 units/kg/hour 2
- aPTT >90 seconds: Hold infusion for 1 hour, then decrease by 3 units/kg/hour 2
Critical Considerations for Efficacy
Early therapeutic anticoagulation is essential: Failure to achieve therapeutic aPTT within 24 hours is associated with a 25% risk of recurrent venous thromboembolism compared to only 2% when adequate anticoagulation is achieved. 1, 6
Underdosing carries significant risk: Studies demonstrate that patients receiving lower initial doses (5,000 unit bolus with 30,000 units/day) had significantly higher recurrence rates than those receiving higher weight-based doses. 1
Common Pitfalls to Avoid
Do not use fixed low-dose regimens for therapeutic anticoagulation: The traditional 5,000 unit bolus with 1,000 units/hour infusion is inadequate and associated with higher recurrence rates. 1, 5
Recognize nonlinear pharmacokinetics: Heparin clearance is dose-dependent and saturable, meaning the anticoagulant effect increases disproportionately with dose—this is why weight-based protocols with frequent monitoring are essential. 1
Avoid confusion with prophylactic dosing: The 5,000 units subcutaneous every 8-12 hours regimen is for prophylaxis only, not therapeutic anticoagulation. 1, 4
Account for variable aPTT reagent sensitivity: Different laboratories use different aPTT reagents with varying sensitivity to heparin, so therapeutic ranges should be validated at your institution. 1, 2
Verify correct vial strength: Fatal medication errors have occurred from confusing therapeutic heparin vials with catheter lock flush products—always confirm the concentration before administration. 4
Special Population Adjustments
Obese patients (≥150 kg): May require lower weight-based infusion rates (approximately 11-13 units/kg/hour) to achieve therapeutic aPTT, though total body weight should still guide initial dosing. 7
Patients over 70 kg: Some protocols cap the initial bolus at 4,000 units and infusion at 1,000 units/hour to prevent excessive anticoagulation, though this is not universally recommended. 3
Renal insufficiency: No dose adjustment needed as heparin is primarily cleared hepatically, making it the preferred anticoagulant in severe renal dysfunction (CrCl <30 mL/min). 2, 3